Strategic

Verfora acquires Qpharma

Pharmaceutical distribution and marketing · Poland

SourcingClub was not involved in this transaction.

Verfora, the consumer healthcare provider of the Galenica Group, acquires 51% of Qpharma. The Polish family business distributes prescription medicines, OTC products and dietary supplements in Poland, the Czech Republic and Slovakia and is already a distribution partner of Verfora.

Deal-Radar editorial team · responsible:

Source from the same day: eqs-news.com , 18 Nov 2026

Who was involved.

Buyer
Verfora
Target
Qpharma
Seller
Inhaberfamilie
Type
Strategic
Country
Poland
Source dated
18/11/2026

Deal-Radar no. 47-060 · publicly reported, no guarantee · SourcingClub was not involved in this transaction. Report an error · Sources and limits

We report publicly announced information and link the source; we accept no liability for its accuracy. No offer and no investment, legal or tax advice. The operators of linked pages are responsible for their content. We correct errors as soon as we learn of them.

Valuation in this industry.

5.9 to 10.0times EBITDA

  • 5.9x to 7.6xRevenue under €5m
  • 7.0x to 9.0x€5m to €50m
  • 8.2x to 10.0xover €50m

Market range for Healthcare & Medical Technology, not the price of this deal. Data basis: DUB KMU-Multiples, Q3/2026; preparation: SourcingClub.

November 2026 on the Deal-Radar.

104 of 269 deals so far are of the type Strategic.

  1. Strategic104
  2. Add-on41
  3. Funding round40
  4. Carve-out29
  5. Buy-out16
  6. Insolvency12
  7. Minority stake11
  8. Secondary8
  9. Succession6
  10. Merger2

New deals every day. By email on Mondays.

All deals of the previous week in one email, with source and adviser.

Weekly email every Monday, in German.

Information from public sources, without guarantee and without claim to completeness. No investment or legal advice. Published on 18 November 2026.